Cargando…
How Can Immune Checkpoint Inhibitors Cause Hyperprogression in Solid Tumors?
Following the administration of immune checkpoint inhibitors, an unexpected pattern of response designated as hyperprogression may be observed in certain patients. This paradoxical response corresponds to an acceleration in tumor growth and a dramatic decrease of patient survival. The reported incid...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098964/ https://www.ncbi.nlm.nih.gov/pubmed/32265935 http://dx.doi.org/10.3389/fimmu.2020.00492 |